Interestingly, compared with healthy controls, serum GLP-1 levels were elevated in patients with IBD [209, 210], DPP-4 expression was increased in T cells, and DPP-4 activity was decreased in the circulation. This evidence concerns the gene GCG and inflammatory bowel disease.